These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
102 related articles for article (PubMed ID: 3499688)
1. Prior administration of donor-strain epidermal cells or macrophages to enhance survival of rat hind-limb allografts. Grisham GR; Black KS; Hewitt CW; Mah BJ; Achauer BM Transplantation; 1987 Oct; 44(4):572-4. PubMed ID: 3499688 [No Abstract] [Full Text] [Related]
2. Peripheral donor leukocytes prolong survival of rat renal allografts. Noris M; Azzollini N; Mister M; Pezzotta A; Piccinini G; Casiraghi F; Cugini D; Perico N; Orisio S; Remuzzi G Kidney Int; 1999 Sep; 56(3):1101-12. PubMed ID: 10469380 [TBL] [Abstract][Full Text] [Related]
3. Role of antibody in rat renal allograft rejection. II. Failure to enhance renal allografts by sensitization to donor class I antigens presented by donor strain erythrocytes. Majoor GD; Van Breda Vriesman PJ Transplantation; 1983 Feb; 35(2):121-6. PubMed ID: 6338632 [TBL] [Abstract][Full Text] [Related]
4. Only B lymphocytes induce active enhancement of rat cardiac allografts. Lauchart W; Alkins BJ; Davies DA Transplantation; 1980 Mar; 29(3):259-61. PubMed ID: 6987792 [TBL] [Abstract][Full Text] [Related]
5. Mesenchymal stem cells enhance the induction of mixed chimerism and tolerance to rat hind-limb allografts after bone marrow transplantation. Pan H; Zhao K; Wang L; Zheng Y; Zhang G; Mai H; Han Y; Yang L; Guo S J Surg Res; 2010 May; 160(2):315-24. PubMed ID: 19524257 [TBL] [Abstract][Full Text] [Related]
6. Composite tissue (limb) allografts in rats. III. Development of donor-host lymphoid chimeras in long-term survivors. Hewitt CW; Black KS; Dowdy SF; Gonzalez GA; Achauer BM; Martin DC; Furnas DW; Howard EB Transplantation; 1986 Jan; 41(1):39-43. PubMed ID: 2867627 [TBL] [Abstract][Full Text] [Related]
10. Enhancement of allograft survival by single intraoperative donor-specific blood transfusion combined with FK506. Fabrega AJ; Blanchard JM; Rivas PA; Pollak R Transplantation; 1993 Dec; 56(6):1579-80. PubMed ID: 7506458 [No Abstract] [Full Text] [Related]
11. [Adenovirus-mediated CTLA4 immunoglobulin based conditioning for non-myeloablative allogeneic hematopoietic cell transplantation to induce tolerance to hind limb allografts in rats]. Pan H; Wang L; Zhang XD; Mai HX; Liu D; Liu Y; Guo SZ Zhonghua Wai Ke Za Zhi; 2009 Jun; 47(12):937-40. PubMed ID: 19781252 [TBL] [Abstract][Full Text] [Related]
12. Suppression of hepatic allograft rejection in the rat by mitomycin C-treated donor splenocytes: analysis of the immune status. Yamaguchi Y; Mori K; Bollinger RR J Clin Lab Immunol; 1990 Jun; 32(2):59-66. PubMed ID: 1967040 [TBL] [Abstract][Full Text] [Related]
13. [Effect of perioperative intraportal administration of donor lymphocytes on skin allografts in rat: preliminary report]. Lee CJ; Yoshimura N; Matsui S; Hamashima T; Oka T Nihon Geka Gakkai Zasshi; 1989 Mar; 90(3):456. PubMed ID: 2671644 [No Abstract] [Full Text] [Related]
14. Tolerance induction to multiple donor rat islet allografts by intrathymic inoculation of spleen cell membrane antigens. Qian T; Ricordi C; Schachner R; Inverardi L; Alejandro R Transplant Proc; 1995 Dec; 27(6):3390. PubMed ID: 8540012 [No Abstract] [Full Text] [Related]
15. Influence of selective splenectomy on survival of cardiac and skin allografts in enhanced rats. Birinyi LK; Baldwin WM; Tilney NL Transplantation; 1980 Jul; 30(1):59-63. PubMed ID: 6994287 [TBL] [Abstract][Full Text] [Related]
16. Enhancement of rat renal allografts with idiotypic and antiidiotypic monoclonal alloantibodies. Stuart FP; Fitch FW; McKearn TJ Transplant Proc; 1982 Jun; 14(2):313-5. PubMed ID: 7051473 [No Abstract] [Full Text] [Related]
17. Protection of heart and rejection of lymphocyte allografts from the same donor in recipients of donor-specific transfusions. Jaskłowska-Englisz M; Olszewski WL; Maksymowicz M; Ziółkowska A Ann Transplant; 1998; 3(1):28-33. PubMed ID: 9869895 [TBL] [Abstract][Full Text] [Related]
18. [Effects of portal venous administration with allogenic cells on renal allograft survival in the rat]. Hamashima T; Yoshimura N; Matsui S; Lee CJ; Oka T Nihon Geka Gakkai Zasshi; 1989 Oct; 90(10):1752-7. PubMed ID: 2480516 [TBL] [Abstract][Full Text] [Related]
19. Immunomodulation for intestinal transplantation by allograft irradiation, adjunct donor bone marrow infusion, or both. Murase N; Ye Q; Nalesnik MA; Demetris AJ; Abu-Elmagd K; Reyes J; Ichikawa N; Okuda T; Fung JJ; Starzl TE Transplantation; 2000 Dec; 70(11):1632-41. PubMed ID: 11152226 [TBL] [Abstract][Full Text] [Related]
20. Synergy between subtherapeutic doses of cyclosporine and immunologic enhancement in rat recipients of cardiac allografts. Padberg WM; Lord RH; Di Stefano R; Araneda D; Tilney NL; Kupiec-Weglinski JW Transplantation; 1988 Jan; 45(1):162-8. PubMed ID: 3276045 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]